Problem: Turner syndrome (TS) affects up to one in 2,000 live female births and is characterized by the total or partial loss of one X chromosome in females with short stature and gonadal dysgenesis. Less penetrant features include sensorineural hearing loss (SNHL), otitis media (OM), pterygium colli, and craniofacial dysmorphism. We report the otolaryngologic features observed in a TS cohort.
Problem: Turner syndrome (TS) affects up to one in 2,000 live female births and is characterized by the total or partial loss of one X chromosome in females with short stature and gonadal dysgenesis. Less penetrant features include sensorineural hearing loss (SNHL), otitis media (OM), pterygium colli, and craniofacial dysmorphism. We report the otolaryngologic features observed in a TS cohort.
Methods: A cohort with a wide spectrum of phenotypic severity has been prospectively ascertained through a multidisciplinary study of genotype-phenotype correlation in TS at the National Institutes of Health. Subjects were evaluated by otolaryngologic examination, pure tone and speech audiometry, tympanometry, and stapedial reflex testing.
Results: Ninety-nine TS patients (age range, 7 to 61 years; average, 30 ) with an average age at diagnosis of 10 years old (range, prenatal to 38 years) were studied. Sixty-three percent of the subjects had a high-arched or a peaked, ogival hard palate. Seventy-one percent had a history of recurrent OM and 64% had SNHL. Cross-sectional analysis revealed 2 predominant patterns of SNHL: adult-onset SNHL affecting high frequencies, and childhood-onset SNHL, initially affecting high or middle frequencies, with eventual progression to severe impairment across all frequencies.
Conclusion: Diagnosis of TS is often delayed until the second decade or later. Almost all TS patients, even the least affected individuals with no external craniofacial stigmata of TS, had at least 1 of 3 otolaryngologic findings: recurrent OM, SNHL, and high-arched or ogival palate.
Significance: The diagnosis of TS is often missed in female children presenting with OM and short stature. In association with a high-arched or ogival palate, or SNHL, these features are useful clinical markers for the initial detection and timely treatment of TS patients. Support: NIH intramural research funds Z01-DC-000064-03 and NICHD DIR Protocol 00-CH-0219.
Head & Neck Surgery
Moderators: Gerry Funk, MD, University of Iowa; Scott Strome, MD, Mayo Clinic; Doug Trask, MD, PhD, University of Iowa. Methods: Between August 1991 and July 2001, 22 patients with vWD type 1 (3 cases, 1 male), vWD type 2A (1 female), vWD type 2B (1 male), vWD type 3 (1 male), haemophilia A-severe type (12 cases, 11 males), 1 female with 30% of factor-VIII level, haemophilia B (2 males, low type), and a female with severe factor X deficiency were studied. Human immunodeficiency virus (HIV) was present in 14, all of them with AIDS. Replacement therapy: cryoprecipitate, activated prothrombin-complex concentrates (APCCs) and/or factor VIII/von Willebrand factor concentrate. Antifibrinolytic agents: Tranexamic acid and/or DDAVP intravenously were used.
Results: Puncturing through the anterior wall of maxillary to lavage and/or to obtain specimens for culture was performed on 10 patients, breaking down as follows: adenoidectomy-4, myringotomy-3, turbinectomy-2, adenotonsillectomy-1, rhinoplasty-1, uvulectomy-1, ethmoidectomy-1, ethmoidectomy and polypectomy by FESS-1, and resection of a large ethmoidal osteoma with skull base invasion-1. One patient was treated with Tranexamic acid, 5 with DDAVP and Tranexamic acid (2 hemophiliacs B, 1 vWD Type 1, 1 vWD type 2 A, 1 with 30% of factor VIII level). One patient received APCCs-severe factor X deficiency. Three patients with vWD were treated with 1 vWD type 1 (high risk surgery), 1 patient with vWD type 2B, and 1 with vWD type 3 need substitution therapy with factor VIII/von Willebrand factor concentrate. Cryoprecipitate and/or factor concentrate were used in all 12 patients with haemophilia A. Those procedures were able to maintain clinical haemostasis. None of the patients had an uncontrolled bleeding, thromboembolic complication, or developed inhibitor--serious complications in patients with hemophilia or vWD.
Conclusion: Meticulous attention to haemostasis, careful preoperative assessment, and postoperative follow-up minimize complications in patients with coagulation deficiencies who require invasive ENT procedures or surgery.
Significance: Hemophiliacs and vWD patients could be submitted to ENT procedures when necessary, but they need special care. Support: None reported. 
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